These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34329527)

  • 21. Biomarkers in major depressive disorder: the role of mass spectrometry.
    Woods AG; Iosifescu DV; Darie CC
    Adv Exp Med Biol; 2014; 806():545-60. PubMed ID: 24952202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma metabolome analysis of patients with major depressive disorder.
    Kawamura N; Shinoda K; Sato H; Sasaki K; Suzuki M; Yamaki K; Fujimori T; Yamamoto H; Osei-Hyiaman D; Ohashi Y
    Psychiatry Clin Neurosci; 2018 May; 72(5):349-361. PubMed ID: 29356314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel urinary metabolite signature for diagnosing major depressive disorder.
    Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
    J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients.
    Stelzhammer V; Guest PC; Rothermundt M; Sondermann C; Michael N; Schwarz E; Rahmoune H; Bahn S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1199-207. PubMed ID: 23183131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
    Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
    J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder.
    Doolin K; Farrell C; Tozzi L; Harkin A; Frodl T; O'Keane V
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDDScore: confirmation of a blood test to aid in the diagnosis of major depressive disorder.
    Bilello JA; Thurmond LM; Smith KM; Pi B; Rubin R; Wright SM; Taub F; Henry ME; Shelton RC; Papakostas GI
    J Clin Psychiatry; 2015 Feb; 76(2):e199-206. PubMed ID: 25742207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry.
    Shin D; Rhee SJ; Lee J; Yeo I; Do M; Joo EJ; Jung HY; Roh S; Lee SH; Kim H; Bang M; Lee KY; Kwon JS; Ha K; Ahn YM; Kim Y
    J Proteome Res; 2021 Jun; 20(6):3188-3203. PubMed ID: 33960196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein Biomarkers in Major Depressive Disorder: An Update.
    Woods AG; Wormwood KL; Iosifescu DV; Murrough J; Darie CC
    Adv Exp Med Biol; 2019; 1140():585-600. PubMed ID: 31347073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular serum signature of treatment resistant depression.
    Ruland T; Chan MK; Stocki P; Grosse L; Rothermundt M; Cooper JD; Arolt V; Bahn S
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):3051-9. PubMed ID: 27325393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive metabolomic and proteomic analyses reveal candidate biomarkers and related metabolic networks in atrial fibrillation.
    Zhou J; Sun L; Chen L; Liu S; Zhong L; Cui M
    Metabolomics; 2019 Jun; 15(7):96. PubMed ID: 31227919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinguishing bipolar from unipolar depression: the importance of clinical symptoms and illness features.
    Leonpacher AK; Liebers D; Pirooznia M; Jancic D; MacKinnon DF; Mondimore FM; Schweizer B; Potash JB; Zandi PP; ; Goes FS
    Psychol Med; 2015 Aug; 45(11):2437-46. PubMed ID: 25851411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study.
    Li Z; Zhang C; Fan J; Yuan C; Huang J; Chen J; Yi Z; Wang Z; Hong W; Wang Y; Lu W; Guan Y; Wu Z; Su Y; Cao L; Hu Y; Hao Y; Liu M; Yu S; Cui D; Xu L; Song Y; Fang Y
    Br J Psychiatry; 2014 Jul; 205(1):29-35. PubMed ID: 24764546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.
    Shi M; Movius J; Dator R; Aro P; Zhao Y; Pan C; Lin X; Bammler TK; Stewart T; Zabetian CP; Peskind ER; Hu SC; Quinn JF; Galasko DR; Zhang J
    Mol Cell Proteomics; 2015 Mar; 14(3):544-55. PubMed ID: 25556233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum peptide profiling for potential biomarkers in early diagnosis of Escherichia coli bloodstream infection.
    Ma Y; Chen C; Yang M; He S; Zhang K; Wang C
    Cytokine; 2019 Aug; 120():71-77. PubMed ID: 31026733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.
    Al Shweiki MR; Oeckl P; Steinacker P; Hengerer B; Schönfeldt-Lecuona C; Otto M
    Expert Rev Proteomics; 2017 Jun; 14(6):499-514. PubMed ID: 28562112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of serum biomarkers predicting development of a subsequent depressive episode in social anxiety disorder.
    Gottschalk MG; Cooper JD; Chan MK; Bot M; Penninx BW; Bahn S
    Brain Behav Immun; 2015 Aug; 48():123-31. PubMed ID: 25929723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum biomarkers predictive of depressive episodes in panic disorder.
    Gottschalk MG; Cooper JD; Chan MK; Bot M; Penninx BW; Bahn S
    J Psychiatr Res; 2016 Feb; 73():53-62. PubMed ID: 26687614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals.
    Han SYS; Cooper JD; Ozcan S; Rustogi N; Penninx BWJH; Bahn S
    Transl Psychiatry; 2019 Nov; 9(1):277. PubMed ID: 31699963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
    Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
    World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.